|
|
Article: Diacrin Elects Henri Termeer to Board of Directors
- Article from:
- PR Newswire
- Article date:
- January 8, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CHARLESTOWN, Mass., Jan. 8 /PRNewswire/ -- Diacrin, Inc. (Nasdaq: DCRN) today announced the election of Henri A. Termeer to its Board of Directors. Mr. Termeer is currently chief executive officer and chairman of Genzyme Corporation (Nasdaq: GENZ), which has become recognized as one of the world's leading biotechnology companies under his leadership. He is also chairman of the Biotechnology Industry Organization (BIO) and a board member of the Massachusetts High Technology Council.
"Diacrin's Board of Directors believes that Mr. Termeer's unequaled breadth and depth of experience in building a leading biotechnology company will significantly benefit our ...